Document is current
Any future updates will be listed below
-
Authors
Safonov, Anton
Lee, Minna
Brown, David N. https://orcid.org/0000-0002-8249-3632
Boscolo Bielo, Luca
Mehine, Miika https://orcid.org/0000-0003-0443-0625
Bandlamudi, Chaitanya https://orcid.org/0000-0003-1108-4919
O’Leary, Ben https://orcid.org/0000-0002-1092-9169
Shao, Hong
Vicente, Laia https://orcid.org/0000-0002-8802-3033
Muldoon, Daniel
Zhu, Allen
Ros, Susana
Marra, Antonio https://orcid.org/0000-0002-7310-7824
Selenica, Pier
Bieche, Ivan
Wubbenhorst, Bradley
Ferraro, Emanuela
Courtois, Laura
El Botty, Rania
Ahmed, Mehnaj
Moiso, Enrico https://orcid.org/0000-0002-4405-8357
An, Julia Ah-Reum
Donoghue, Mark T. A. https://orcid.org/0000-0003-4538-6069
Will, Marie
Pareja, Fresia https://orcid.org/0000-0003-3748-8049
Nizialek, Emily
Lukashchuk, Natalia
Sofianopoulou, Eleni
Liu, Yuan
Huang, Xin
Chappey, Colombe
Staniszewska, Anna D. https://orcid.org/0000-0003-1328-1959
Ross, Dara
Mandelker, Diana
Ladanyi, Marc https://orcid.org/0000-0001-9055-7213
Schultz, Nikolaus https://orcid.org/0000-0002-0131-4904
Berger, Michael F. https://orcid.org/0000-0003-3882-5000
Scaltriti, Maurizio
Reis-Filho, Jorge S.
Li, Bob T.
Offit, Kenneth
Norton, Larry
Shen, Ronglai https://orcid.org/0000-0001-9694-584X
Maxwell, Kara N.
Couch, Fergus https://orcid.org/0000-0001-9417-9985
Domchek, Susan M. https://orcid.org/0000-0002-5914-7272
Marangoni, Elisabetta https://orcid.org/0000-0002-3337-6448
Shah, Sohrab https://orcid.org/0000-0001-6402-523X
Albertella, Mark R. https://orcid.org/0000-0003-4406-6135
Serra, Violeta https://orcid.org/0000-0001-6620-1065
Weigelt, Britta https://orcid.org/0000-0001-9927-1270
Solit, David B. https://orcid.org/0000-0002-6614-802X
Nathanson, Katherine L. https://orcid.org/0000-0002-6740-0901
Robson, Mark E. https://orcid.org/0000-0002-3109-1692
Turner, Nicholas C. https://orcid.org/0000-0001-8937-0873
Chandarlapaty, Sarat https://orcid.org/0000-0003-4532-8053
Razavi, Pedram https://orcid.org/0000-0003-4236-0576
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 23 January 2026
First Online: 4 March 2026
Competing interests
: A.S. has received travel support from Novartis. J.S.R.-F., M.S., E.N., N.L., E.S., S.R., M.R.A., A.D.S. and V.S. are currently employed by AstraZeneca. Y.L. and X.H. are currently employed by Pfizer. M.F.B. has received consultation from AstraZeneca, Eli Lilly and Paige AI; has received research support from Boundless Bio; and declares intellectual property interests with SOPHiA Genetics. B.T.L. is a current employee and stockholder of AstraZeneca, and the research was conducted while he served as faculty at MSK; he has served as an uncompensated advisor and consultant to Amgen, AstraZeneca, Boehringer Ingelheim, Bolt Biotherapeutics, Daiichi Sankyo, Genentech and Lilly; has received research grants to his institution from Amgen, AstraZeneca, Bolt Biotherapeutics, Daiichi Sankyo, Genentech, Lilly, Nuvalent and Revolution Medicines; is an inventor on three institutional patents at MSK (US62/685,057, US62/514,661 and US63/424,813); and has intellectual property rights as a book author at Karger Publishers and Shanghai Jiao Tong University Press. M. Lee reports equity and professional services and activites from Biologica. S.C. has received institutional grants or funding from Daiichi Sankyo and AstraZeneca; share options in Totus Medicines; and consultation, ad board or honoraria from Daiichi Sankyo, AstraZeneca, Lilly, Casdin Capital, Merck and Pathos AI. P.R. has received institutional grants and/or funding from Grail, Novartis, AstraZeneca, Invitae, Biothernostics, Tempus, Neogenomics, Guardant Health, Personalis, Myriad Genetics, Foresight Diagnostics, Natera, Biodesix, SAGA Diagnostics, SOPHiA Genetics, Haystack and Roche; and consultation, ad board or honoraria from Novartis, AstraZeneca, Lilly/Loxo, Stemline Therapeutics, Prelude Therapeutics, Neogenomics, Regor Pharmaceuticals, SAGA Diagnostics, SOPHiA Genetics, Tempus, Myriad Genetics, Foresight Diagnostics, Natera, Pathos AI and BioNTech. The other authors declare no competing interests.
